Bioton Stock

Bioton Debt 2024

Bioton Debt

64.81 PLN

Ticker

BIO.WA

ISIN

PLBIOTN00029

WKN

A0D9SD

In 2024, Bioton's total debt was 64.81 PLN, a -3.35% change from the 67.05 PLN total debt recorded in the previous year.

Bioton Aktienanalyse

What does Bioton do?

Bioton SA is a leading Polish biotechnology company specializing in the development of innovative drugs, diagnostics, and medical devices. The company was founded in 1989 and has since achieved remarkable success. Bioton is headquartered in Poland and employs approximately 1000 people worldwide. The company is listed on the Warsaw Stock Exchange and is supported by renowned investors. Business model Bioton operates various business divisions, including research and development, production, sales, as well as marketing and distribution. The company collaborates closely with leading academic institutions and research organizations and invests significant resources in the development of new groundbreaking technologies and products. The company's products and services are distributed and used in over 60 countries worldwide. Divisions Bioton is divided into three main business sectors, including biopharmaceuticals, diagnostics, and medical devices. Biopharmaceuticals Bioton is known for its biopharmaceuticals, particularly insulin and insulin analogs. Insulin is a hormone produced by the body to regulate blood sugar levels. Bioton offers various insulin products, including human insulin, insulin glargine, and insulin aspart. These products are approved for the treatment of diabetes mellitus and are distributed in over 50 countries worldwide. Diagnostics Bioton is also involved in the development and production of diagnostics. The company offers various testing systems for the diagnosis of infectious diseases, allergies, and autoimmune diseases. The product line also includes in vitro diagnostics that are used for medical therapy monitoring and disease detection. Medical devices Bioton also manufactures and distributes medical devices such as insulin pumps and blood glucose meters. These devices are designed for people with diabetes and assist in accurate insulin dosing and blood sugar level monitoring. Products In addition to insulin and insulin analogs, Bioton also produces a wide range of other drugs, including growth hormones, as well as follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones are used for the treatment of infertility. Bioton is also involved in the development of novel technologies such as RNA interference (RNAi) and genomic research. The company invests significantly in innovative research projects aimed at the development of groundbreaking drugs and therapies. In conclusion, Bioton SA is a highly innovative biotechnology company with a wide range of products and a focus on research and development. The company operates in the global market and collaborates closely with renowned institutions and research organizations. Bioton's business model is based on the development of innovative technologies and products aimed at improving the quality of life for people worldwide. Bioton ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Bioton's Debt Structure

Bioton's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Bioton's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Bioton’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Bioton’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Bioton stock

What is the debt of Bioton this year?

Bioton has a debt level of 64.81 PLN this year.

What was the debt of Bioton compared to the previous year?

The debt of Bioton has increased by -3.35% compared to the previous year dropped.

What are the consequences of high debt for investors in Bioton?

High debt can pose a risk for investors of Bioton, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Bioton?

Low debt means that Bioton has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Bioton affect the company?

An increase in debt of Bioton can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Bioton affect the company?

A reduction in debt of Bioton can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Bioton?

Some factors that can influence the debt of Bioton include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Bioton so important for investors?

The debts of Bioton are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Bioton take to change the debt?

To change the debt, Bioton can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Bioton pay?

Over the past 12 months, Bioton paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioton is expected to pay a dividend of 0 PLN.

What is the dividend yield of Bioton?

The current dividend yield of Bioton is .

When does Bioton pay dividends?

Bioton pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bioton?

Bioton paid dividends every year for the past 0 years.

What is the dividend of Bioton?

For the upcoming 12 months, dividends amounting to 0 PLN are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bioton located?

Bioton is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bioton kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bioton from 10/21/2024 amounting to 0 PLN, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did Bioton pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of Bioton in the year 2023?

In the year 2023, Bioton distributed 0 PLN as dividends.

In which currency does Bioton pay out the dividend?

The dividends of Bioton are distributed in PLN.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bioton

Our stock analysis for Bioton Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioton Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.